Low expression of < em > GOT2 < /em > promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma

Conclusion: GOT2 plays a tumor-inhibitory role in HCC and may be a potential therapeutic target for HCC.PMID:38095985 | DOI:10.2217/bmm-2023-0236

Source: Future Medicine: Biomarkers in Medicine - December 14, 2023 Category: Internal Medicine Authors: Qiuli Liang Shun Liu Fuqiang Yin Meiliang Liu Lijun Wang Erna Guo Lei Lei Liuyu Wu Yu Yang Di Zhang Xiaoyun Zeng Source Type: research